Nathan Dubois^1*, David Van Morkhoven^1*, Laurentijn Tilleman^2*, Filip Van Nieuwerburgh^2*, Dominique Bron^3*, Laurence Lagneaux^4* and Basile Stamatopoulos^5*

¹Laboratory of Clinical Cell Therapy, University of Brussels (ULB), Jules Bordet Institute, Brussels, Belgium
²Ghent University, Ghent, Belgium
³Institut J. Bordet, Brussel, BEL
⁴Laboratory of Clinical Cell Therapy, University of Brussels (ULB), Jules Bordet Institute, Brussels, BEL
⁵Laboratory of Clinical Cell Therapy, Dept. of Experimental Hem., Brussels, Belgium

Heng Li, MD^1*, Ji Li, MD^2*, Ming Luo^3*, Peilong Wang^1*, Yue Sheng, PhD⁴ and Hongling Peng^1*

¹Department of Hematology, The Second Xiangya Hospital, Central South University, Changsha, China
²Department of hematology, The second xiangya hospital of Central South University, Changsha, China
³The Second Xiangya Hospital, Central South University, Changsha, China
⁴Department of Hematology, The Second XIANGYA Hospital, Changsha, China

Layla M. Saleh^1*, Maissa Mhibik, PhD^1*, Heribert Playà-Albinyana^1,2*, Clare Sun, MD¹, Christopher Pleyer, MD^1* and Adrian Wiestner, MD³

¹Laboratory of Lymphoid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
²Institut D'Investigacions BiomèDiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain
³Laboratory of Lymphoid Malignancies, Hematology Branch, NIH, NHLBI, Bethesda, MD

Miguel Arguello De Tomas^1*, Elionor Lynton-Pons^1*, Nil Albiol, MD^2*, Jorge Sierra, MD¹, Esther Moga^1* and Carol Moreno^3*

¹Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
²Hematology Department, Hematology Department, Hospital Clínic Barcelona, Barcelona, Spain, Barcelona, Spain
³Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Josep Carreras Leukaemia Research Institute, Barcelona, Spain

Negin Karisani, PhD^1,2*, Amit Sud, MD, PhD, FRCPath, MRCP^3,4,5*, Liang Li, MS^1*, Satyen Gohil, MD PhD^3,6*, Kristy Schlueter-Kuck, PhD^1*, Laura Rassenti, PhD^7*, Tuan N. Tran^7*, Leo Wang-Kit Cheung, PhD, MSc, BS^8*, Iliana Edith Szafer-Glusman, PhD^8*, James P. Dean, MD, PhD^8*, Guang Chen^1*, Junko Tsuji, PhD^1*, Neil E. Kay, MD^9,10, Kanti R. Rai^11,12, Jennifer R. Brown, MD, PhD^4,13, John G. Gribben, MD¹⁴, John C. Byrd, MD¹⁵, Donna S. Neuberg, ScD¹⁶, Chip Stewart, PhD^1*, Ivana Bozic, PhD^17*, Thomas J. Kipps, MD^18,19,20, Gad Getz, PhD^1,4,21* and Catherine J. Wu, MD^1,3,4*

¹Broad Institute of MIT and Harvard, Cambridge, MA
²Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA
³Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁴Harvard Medical School, Boston, MA
⁵Centre for Immuno-Oncology, University of Oxford, Oxford, United Kingdom
⁶University College London Hospitals NHS Foundation Trust, London, United Kingdom
⁷Center for Novel Therapeutics, University of California, La Jolla, CA
⁸Pharmacyclics LLC, an AbbVie Company, South San Francisco, CA
⁹Department of Immunology, Mayo Clinic, Rochester, MN
¹⁰Division of Hematology, Mayo Clinic, Rochester, MN
¹¹Department of Medicine, Northwell Health, Manhasset, NY
¹²Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY
¹³Department of Medical Oncology, Dana-Farber Cancer Institute, Newton, MA
¹⁴Barts Cancer Institute, Queen Mary University of London, London, United Kingdom
¹⁵Department of Internal Medicine, University of Cincinnati, Cincinnati, OH
¹⁶Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
¹⁷Department of Applied Mathematics, University of Washington, Seatlle, WA
¹⁸Center for Novel Therapeutics, University of California, San Diego, La Jolla, CA
¹⁹Division of Hematology Oncology, Department of Medicine, University of California, San Diego, La Jolla, CA
²⁰Moores Cancer Center, University of California, San Diego, La Jolla, CA
²¹Department of Pathology, Massachusetts General Hospital, Boston, MA

Heribert Playà-Albinyana^1,2,3*, Alba Garcia-Perez^4,5*, Sara Otin^4,6*, Miquel Castellote-Borrell, MSc^7,8*, Elias Campo, MD, PhD^9,10, Patricia Perez Galan, PhD^11,12*, Judith Guasch^4,8,13* and Dolors Colomer^1,2,14,15*

¹Universitat de Barcelona (UB), Barcelona, Spain
²Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain
³Institut D'Investigacions BiomèDiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain
⁴Institute of Materials Science of Barcelona (ICMAB-CSIC), Bellaterra, Spain
⁵Dynamic Biomimetics for Cancer Immunotherapy, Max Planck Partner Group, Barcelona, Spain
⁶Fundació de Recerca Clínic Barcelona Institut d’Investigacions Biomèdiques August Pi i Sunyer (FCB-IDIBAPS), Barcelona, Spain
⁷nstitute of Materials Science of Barcelona (ICMAB-CSIC), Bellaterra, Spain
⁸Dynamic Biomimetics for Cancer Immunotherapy, Max Planck Partner Group, ICMAB-CSIC, Bellaterra, Spain
⁹Hematopathology Section, Department of Pathology, Hospital Clínic of Barcelona, Barcelona, Spain
¹⁰Hospital Clinic Provincial, Barcelona, ESP
¹¹Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, ESP
¹²Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain
¹³Centro de Investigación Bimédica en Red de Bioingeniería, Biomateriales y Nanotecnologia (CIBERBBN), Madrid, Spain
¹⁴Hematopathology Section, Pathology Department, Hospital Clínic de Barcelona, Barcelona, Spain
¹⁵Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain

Andres Chang, MD, PhD^1,2, Adam Pelletier, PhD^3*, Donald J McGuire, PhD^1*, Maria Tsagiopoulou^4*, Maria Karipidou^5*, Amy Ayers, MPH^6*, Alyssa Leal^6*, Michael Churnetski, BS^6*, Colin B O'Leary, MA^6*, Jeffrey M. Switchenko, PhD, MS^7*, Carl Davis, MD, PhD^1*, David A. Frank, MD, PhD⁶, Jean L. Koff, MD, MSc⁶, Jonathon B Cohen, MD MS⁶, Rafick-Pierre Sekaly^7*, Kostas Stamatopoulos, MD⁸, Christopher R. Flowers, MD, MS^6,9 and Rafi Ahmed, PhD^1*

¹Emory Vaccine Center, Emory University, Atlanta, GA
²Department of Hematology and Medical Oncology, Emory University, Atlanta, GA
³Emory Vaccine Center, Emory University, Atlanta
⁴Institute of Applied Biosciences, Centre For Research and Technology Hellas, Thessaloniki, GRC
⁵Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece
⁶Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
⁷Emory University, Atlanta, GA
⁸Institute of Applied Biosciences, Centre for Research and Technology Hellas, Asvestohori, Greece
⁹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Bofei Wang, PhD¹, Jessica Lynn Root, MS^2*, Araceli Isabella Garza^3*, Joyce Breaker^4*, William G. Wierda³, Hussein A. Abbas, MD, PhD³ and Patrick K. Reville, MD, MPH³

¹Department of Leukemia, Division of Cancer Medicine, The University of Texas At MD Anderson Cancer Cent, Houston, TX
²Department of Leukemia, The University of Texas MD Anderson Cancer center, Houston, TX
³Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Leukemia, University of Texas MD Anderson Cancer Center, HOUSTON, TX